pembrolizumab,mrna-4157
merck,moderna
['melanoma']
new research presented at the annual meeting 2023 shows that a personalized mrna vaccine may help prevent recurrence in advanced melanoma patients. #aacr23 
A magazine that educates and empowers cancer patients, survivors and caregivers.